Audentes Therapeutics is based out of San Francisco. Audentes Therapeutics, Inc. operates as a biotechnology company. The Company focuses on the development and commercialization of gene therapy treatments for people with serious rare diseases. Audentes Therapeutics serves customers in the United States.Whalewisdom has at least 1 13D filings, and 47 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2015-10-22. The notice included securities offered of Equity
Contact Info
Contact information is taken directly from publicly disclosed SEC filings.
AUDENTES THERAPEUTICS, INC.600 CALIFORNIA ST., 17TH FLOOR
SAN FRANCISCO CA 94108
Business Phone: 415-638-6556
SEC SIC CODE:
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Current 13D/G Holdings
Stock | Sector | Shares Held | Market Value | Rank | Source | Source Date |
---|---|---|---|---|---|---|
Taysha Gene Therapies, Inc. | HEALTH CARE | 7,266,342 | 12,861,425 | 1 | 13D | 2022-10-31 |